1Wada H, Tanigawa M, Wakita Y, et al. Increased plasma level of interleukin - 6 in disseminated intravascular coagulation[J]. Blood Coagul Fibrinolysis, 1993,4(4):583 - 590.
2Levi M, Ten Cate H. Dissminated intravascular coagulation[J].N Engl J Med, 1999,341(8):586- 592.
3Carey M J, Rodgers GM. Disseminated intravascular coagulation:cinical and laboratory aspects[J]. Am J Hematol, 1998, 59 (1):65 - 73.
4Ono S, Mochizuki H, Tamakuma S. A clinical study on the significance of platelet- activating factor in the pathophysiology of septic diseminated intravascular coagulation in surgery[J]. Am J Surg, 1996,171,(4):409 - 415.
5Rakic s, New findings on the physiopathology of acute hemolytic transfusion reactions[J]. Med Pregl, 1999,52(1/2):19 - 24.
7Kessler CM, Tang Z, Jacobs HM, et al. The suprapharmacological dising of antithrombin concentrate for Staphylococcus aureusinduced disseminated intravascular coagulation in guinea pigs:substantial reduction in mortality and morbidity[J]. Blood, 1997,89(12):4393 - 4401.
8Ghosh TK, Khan N, Malik A. Platelet auto-antibodies in septicaemic patients[J]. Indean J Pathal Microbiol[J]. 1999,42(1):31 - 35.
9Baglin T. Disseminated intravascular coagulation: diagnosis and treatment[J]. Br Med J, 1996,312(7032):683- 687.
10Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapetic response[J]. Semin Thromb Haemost, 1996,22(1):69- 88.
